在瑞典人群队列中评估ACR/EULAR 2022年ANCA相关性血管炎分类标准
该研究在374例ANCA相关性血管炎患者中评估ACR/EULAR 2022分类标准,并与EMA算法及仅基于ANCA血清学的分类比较;EMA与ACR/EULAR分类结果相似,GPA、MPA、EGPA观察一致率分别为85%、75%、96%,加权κ为0.66(95%CI:0.60,0.74)。
要点
- EMA与ACR/EULAR分类结果相似,GPA、MPA、EGPA观察一致率分别为85%、75%、96%,加权κ为0.66(95%CI:0.60,0.74)。
- 4例(1.1%)符合两个疾病分类标准,13例(3.5%)无法分类。
- 188例PR3-ANCA阳性患者中186例(98.9%)按ACR/EULAR分类为GPA,161例MPO-ANCA阳性患者中135例(83.9%)分类为MPA。
核心结论
- EMA与ACR/EULAR分类结果相似;少部分患者无法分类或落入两个类别。
- 部分表现肉芽肿(GPA关键特征)的患者仍被分类为MPA,与当前AAV组织病理学观点相冲突。
- 基于ANCA的分类与ACR/EULAR分类高度一致,反映新标准赋予ANCA相当大的权重;新标准中这些关键要素需领域专家共识讨论。
研究设计与样本
- 基于瑞典人群的队列研究,纳入374例(47%为女性)ANCA相关性血管炎病例,按EMA算法、ANCA血清学和ACR/EULAR标准进行分类,用κ统计量计算一致率。
主要发现
- EMA分类:GPA 192例、MPA 159例、EGPA 23例;ACR/EULAR分类:GPA 199例、MPA 136例、EGPA 22例。
- 4例(1.1%)符合两个疾病类别标准,13例(3.5%)无法分类。
- EMA与ACR/EULAR观察一致率:GPA 85%、MPA 75%、EGPA 96%;未加权κ为0.66(95%CI:0.60,0.74)。
- 188例PR3-ANCA阳性患者中186例(98.9%)按ACR/EULAR分类为GPA;161例MPO-ANCA阳性患者中135例(83.9%)分类为MPA。
- 仅基于ANCA特异性的分类与ACR/EULAR的一致率:GPA 99%、MPA 88%。
关键数值与推荐
- ACR/EULAR 2022分类标准:GPA 199例、MPA 136例、EGPA 22例;4例(1.1%)符合两个类别,13例(3.5%)无法分类。
- EMA算法:GPA 192例、MPA 159例、EGPA 23例。
- EMA与ACR/EULAR观察一致率:GPA 85%、MPA 75%、EGPA 96%;未加权κ 0.66(95%CI:0.60,0.74)。
- PR3-ANCA阳性188例中186例(98.9%)按ACR/EULAR分类为GPA;MPO-ANCA阳性161例中135例(83.9%)分类为MPA。
- 仅基于ANCA特异性分类与ACR/EULAR一致率:GPA 99%、MPA 88%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the ACR/EULAR 2022 criteria for ANCA-associated vasculitides (AAV) classification and compare them with the European Medicines Agency (EMA) algorithm and with classification based only on ANCA serology. METHODS: In the analysis, 374 cases (47% female) were classified according to the EMA algorithm, ANCA serology and ACR/EULAR criteria. The agreement rate was calculated using the kappa (κ) statistic. RESULTS: Under EMA, 192 patients were classified as granulomatosis with polyangiitis (GPA), 159 as microscopic polyangiitis (MPA) and 23 as eosinophilic granulomatosis with polyangiitis (EGPA). The ACR/EULAR criteria classified 199 patients as GPA, 136 as MPA and 22 as EGPA. Four patients (1.1%) met criteria of two disease categories, and 13 (3.5%) were unclassifiable. The observed agreement between EMA and ACR/EULAR was 85% for GPA, 75% for MPA and 96% for EGPA. The unweighted κ statistic was 0.66 (95% CI: 0.60, 0.74). Of the 188 PR3-ANCA positive patients, 186 (98.9%) were classified as GPA using ACR/EULAR criteria, and 135 of 161 (83.9%) MPO-ANCA positive patients were classified as MPA. With a classification solely based on ANCA specificity, agreement with ACR/EULAR was 99% for GPA and 88% for MPA. CONCLUSIONS: EMA and ACR/EULAR classification give similar results. A small proportion of patients cannot be classified or fall into two categories. Some patients exhibiting granuloma, a key feature of GPA, are nevertheless classified as MPA, conflicting with the current view of histopathology of AAV. There is high agreement of ANCA-based classification with that of ACR/EULAR, reflected in the considerable weight granted to ANCA in the new criteria. These crucial elements within the new criteria necessitate a consensus discussion among field experts.
引用
- Rathmann J, Segelmark M, Mohammad AJ, et al. Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden. Rheumatology (Oxford). 2024. PMID: 37758240. doi:10.1093/rheumatology/kead516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。